https://www.selleckchem.com/pr....oducts/eribulin-mesy
The purpose of this cross-sectional retrospective study was to utilize EpiTrack to assess cognitive performance within the domain of attention and executive functions in patients with refractory epilepsy in consideration for treatment interventions either with antiepileptic drug (AED) changes and/or neuromodulation therapies. We also aimed to identify the relevant clinical and treatment factors possibly affecting EpiTrack performance. The patient group consisted of 95 consecutive refractory epilepsy patients who were eva
Like
Comment
Share
